Targeting DNA Repair Pathways in Hematological Malignancies

被引:13
|
作者
Alhmoud, Jehad F. [1 ]
Mustafa, Ayman G. [2 ]
Malki, Mohammed Imad [2 ]
机构
[1] Al Ahliyya Amman Univ, Fac Appl Med Sci, Dept Med Lab Sci, Amman 19328, Jordan
[2] Qatar Univ, QU Hlth, Coll Med, POB 2713, Doha, Qatar
关键词
DNA repair; DNA damage; hematological malignancies; apoptosis; mutation; ACUTE MYELOID-LEUKEMIA; MANTLE CELL LYMPHOMA; DOUBLE-STRAND BREAKS; ACUTE LYMPHOBLASTIC-LEUKEMIA; DAMAGE RESPONSE; ATAXIA-TELANGIECTASIA; SYNTHETIC LETHALITY; GENOMIC INSTABILITY; EPIGENETIC THERAPY; INHIBITOR MK-8776;
D O I
10.3390/ijms21197365
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
DNA repair plays an essential role in protecting cells that are repeatedly exposed to endogenous or exogenous insults that can induce varying degrees of DNA damage. Any defect in DNA repair mechanisms results in multiple genomic changes that ultimately may result in mutation, tumor growth, and/or cell apoptosis. Furthermore, impaired repair mechanisms can also lead to genomic instability, which can initiate tumorigenesis and development of hematological malignancy. This review discusses recent findings and highlights the importance of DNA repair components and the impact of their aberrations on hematological malignancies.
引用
收藏
页码:1 / 17
页数:17
相关论文
共 50 条
  • [41] Targeting the canonical Wnt/-catenin pathway in hematological malignancies
    Ashihara, Eishi
    Takada, Tetsuya
    Maekawa, Taira
    CANCER SCIENCE, 2015, 106 (06) : 665 - 671
  • [42] Targeting SHP2 phosphatase in hematological malignancies
    Kanumuri, Rahul
    Kumar Pasupuleti, Santhosh
    Burns, Sarah S.
    Ramdas, Baskar
    Kapur, Reuben
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2022, 26 (04) : 319 - 332
  • [43] Targeting the JAK2 kinase in hematological malignancies
    Olsen, Colin E.
    Gourley, Eric S.
    Lui, Xiao-Hui
    Walker, Jeff
    Grand, Cory L.
    Warner, Steven L.
    Vankayalapati, Hariprasad
    Bearss, David J.
    BLOOD, 2007, 110 (11) : 1041A - 1042A
  • [44] Apoptosis induced by molecular targeting therapy in hematological malignancies
    Adachi, S
    Leoni, LM
    Carson, DA
    Nakahata, T
    ACTA HAEMATOLOGICA, 2003, 111 (1-2) : 107 - 123
  • [45] Targeting the DNA Damage Response and DNA Repair Pathways to Enhance Radiosensitivity in Colorectal Cancer
    Deng, Siyao
    Vlatkovic, Tijana
    Li, Moying
    Zhan, Tianzuo
    Veldwijk, Marlon R.
    Herskind, Carsten
    CANCERS, 2022, 14 (19)
  • [46] Therapeutics targeting Bcl-2 in hematological malignancies
    Ruefli-Brasse, Astrid
    Reed, John C.
    BIOCHEMICAL JOURNAL, 2017, 474 : 3643 - 3657
  • [47] Therapeutic Targeting of Notch Signaling Pathway in Hematological Malignancies
    Sorrentino, Claudia
    Cuneo, Antonio
    Roti, Giovanni
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2019, 11
  • [48] Nanotechnology in Cancer Therapy: Targeting the Inhibition of Key DNA Repair Pathways
    Aziz, K.
    Nowsheen, S.
    Georgakilas, A. G.
    CURRENT MOLECULAR MEDICINE, 2010, 10 (07) : 626 - 639
  • [49] Impact of Histone Modifications and Their Therapeutic Targeting in Hematological Malignancies
    Markouli, Mariam
    Strepkos, Dimitrios
    Piperi, Christina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [50] Targeting myeloid cells for hematological malignancies: the present and future
    Zihui Guan
    Zhengqi Zhang
    Kaiyan Wang
    Shukai Qiao
    Teng Ma
    Lina Wu
    Biomarker Research, 13 (1)